期刊文献+

血管内治疗与药物治疗症状性颅内动脉狭窄的疗效比较 被引量:7

Efficacy observation of endovascular therapy and medical therapy for symptomatic intracranial artery stenosis
下载PDF
导出
摘要 目的:探讨血管内治疗与单纯药物治疗症状性颅内动脉狭窄的疗效。方法回顾性分析颅内动脉狭窄145例患者的临床资料,根据患者或家属意愿分为血管内治疗组72例和药物治疗组73例,分别行血管内治疗手术(使用Gateway球囊、Wingspan支架、Apollo支架)或药物治疗(阿司匹林100 mg /d、氯吡格雷75 mg/d、阿托伐他汀2040 mg/d),随访观察1、3、6、9、12个月的卒中及短暂性脑缺血发作(TIA)发生率、再狭窄率(以狭窄率〉50%为标准),并进行两组间比较。结果(1)血管内治疗组在药物治疗基础上成功置入支架70枚,支架置入成功率为98.6%(70/71);血管内治疗组共发生并发症7例(9.9%),其中合并出血2例,饮水呛咳、声音嘶哑、眩晕、头痛、兴奋各1例;1例脑出血病情恶化死亡,其他患者经积极内科治疗均痊愈出院,未遗留严重后遗症。(2)血管内治疗组治疗后12个月卒中复发率为8.4%(6例,均为TIA),药物治疗组为26.0%[19例,其中16例(占84.2%)为小卒中],差异有统计学意义(χ2=7.752,P〈0.01);治疗后12个月两组再狭窄发生率或狭窄加重发生率分别为5.6%(4例)和6.8%(5例),差异无统计学意义(χ2=0.091,P〉0.05)。结论血管内治疗症状性颅内动脉狭窄与药物治疗比较,疗效更显著,改善患者临床预后优于药物治疗。 Objective To investigate the efficacy comparison of endovascular therapy and simple medical therapy for symptomatic intracranial artery stenosis. Methods A total of 145 patients with intracranial artery stenosis were analyzed retrospectively. They were divided into either an endovascular therapy group (n=72) or a medical therapy group (n=73). They were treated with endovascular therapy (gateway balloon,wingspan stents,Apollo stents) or medical therapy (aspirin 100 mg/d,clopidogrel 75mg/d, and atorvastatin 20-40 mg/d) according the willingness of the patients or their family members. The incidences of stroke and transient ischemic attack ( TIA ) , and restenosis rate ( stenosis rate 〉50% as a standard) during 1-,3-,6-,9-,and 12-month follow-up periods were observed and compared. Results On the basis of medical therapy,the patients of the endovascular therapy group were successfully stented. The success rate of stenting was 98. 6% (70/71). Seven patients had complications in the endovascular therapy group (9.9%),2 of them complicated with hemorrhage(one of was died),drinking cough,hoarseness, dizziness,headache,and excitement were one case in each, the other patients were cured and discharged with active medical treatment, and they did not have serious sequelae. At 12 months after treatment, the stroke recurrence rate of the endovascular therapy group was 8. 4% (n=6,both were TIA),and that of the medical therapy group was 26. 0% (84. 2% was minor stroke). There was significant difference (χ2 =7. 752,P〈0. 01);at 12 months after treatment,the incidences of restenosis and aggravated stenosis were 5. 6% (n=4) and 6. 8% (n=5) respectively. There was no significant difference (χ2 =0. 091,P〉0. 05). Conclusion Compared with the medical therapy,the efficacy of endovascular therapy for symptomatic intra-cranial arterial stenosis is more significant. The improvement of clinical prognosis is superior to medical therapy.
出处 《中国脑血管病杂志》 CAS 2014年第6期294-299,共6页 Chinese Journal of Cerebrovascular Diseases
关键词 颅内动脉疾病 血管内操作 支架 多种药物疗法 再狭窄 Intracranial arterial disease Endovascular procedures Stent Polypharmacy Restenosis
  • 相关文献

参考文献15

二级参考文献80

共引文献61

同被引文献66

  • 1刘一强,杜丽娟,王天玉.血管内介入与单纯药物治疗老年重度颅内前循环动脉狭窄的疗效[J].中国老年学杂志,2015,35(1):70-71. 被引量:10
  • 2陶庆玲,孙瑄,赵晖,姚胜旗.颅内动脉狭窄的支架成形术与内科治疗的疗效观察[J].中华神经外科杂志,2006,22(4):233-235. 被引量:36
  • 3Chimowitz MI,Lynn MJ,Derdeyn CP,et al.Stenting versus aggressive medical therapy for intracranial arterial stenosis.N Engl J Med,2011,365:993-1003. 被引量:1
  • 4Yu SC,Leung TW,Lee KT,et al.Angioplasty and stenting of atherosclerotic middle cerebral arteries with Wingspan:evaluation of clinical outcome,restenosis,and procedure outcome.AJNR Am J Neuroradiol,2011,32:753-758. 被引量:1
  • 5Jin M,Fu X,Wei Y,et al.Higher risk of recurrent ischemic events in patients with intracranial in-stent restenosis.Stroke,2013,44:2990-2994. 被引量:1
  • 6Lutsep HL.Symptomatic intracranial stenosis:best medical treatment vs.intracranial stenting.Curr Opin Neurol,2009,22:69-74. 被引量:1
  • 7Zhu SG,Zhang RL,Liu WH,et al.Predictive factors for instent restenosis after balloon-mounted stent placement for symptomatic tracranial atherosclerosis.Eur J Vasc Endovasc Surg,2010,40:499-506. 被引量:1
  • 8Hussain MS,Fraser JF,Abruzzo T,et al.Standard of practice:endovascular treatment of intracranial atherosclerosis.J Neurointerv Surg,2012,4:397-406. 被引量:1
  • 9Yue X,Yin Q,Xi G,et al.Comparison of BMSs with SES for symptomatic intracranial disease of the middle cerebral artery stenosis.Cardiovasc Intervent Radiol,2011,34:54-60. 被引量:1
  • 10Guo X,Shi N,Cui XB,et al.Dedicator of cytokinesis 2,a novel regulatorfor smooth muscle phenotypic modulation and vascular remodeling.Circ Res,2015,116:e71-e80. 被引量:1

引证文献7

二级引证文献52

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部